https://nl.marketscreener.com/koers/aandeel/SYNDAX-PHARMACEUTICALS-IN-16725742/nieuws/Syndax-Pharmaceuticals-kondigt-aan-dat-de-resultaten-van-de-cruciale-AGAVE-201-studie-met-axatilimab-45225744/?utm_source=telegram&utm_medium=social&utm_campaign=share